1. Ma, Yan-Fei, Chen, Yongcheng, Fang, Dalang, Huang, Qun, Lu, Guan-Ming. . The immune-related gene CD52 is a favorable biomarker for breast cancer prognosis. In Gland surgery, 10, 780-798. doi:10.21037/gs-20-922. https://pubmed.ncbi.nlm.nih.gov/33708560/
2. Hu, Yongxian, Zhou, Yali, Zhang, Mingming, Ren, Jiangtao, Huang, He. 2021. CRISPR/Cas9-Engineered Universal CD19/CD22 Dual-Targeted CAR-T Cell Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia. In Clinical cancer research : an official journal of the American Association for Cancer Research, 27, 2764-2772. doi:10.1158/1078-0432.CCR-20-3863. https://pubmed.ncbi.nlm.nih.gov/33627493/
3. Domagała, A, Kurpisz, M. . CD52 antigen--a review. In Medical science monitor : international medical journal of experimental and clinical research, 7, 325-31. doi:. https://pubmed.ncbi.nlm.nih.gov/11257744/
4. Chiesa, Robert, Georgiadis, Christos, Syed, Farhatullah, Vora, Ajay, Qasim, Waseem. 2023. Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lymphoblastic Leukemia. In The New England journal of medicine, 389, 899-910. doi:10.1056/NEJMoa2300709. https://pubmed.ncbi.nlm.nih.gov/37314354/
5. Boyne, Alex, Yang, Ming, Pulicani, Sylvain, Duchateau, Philippe, Juillerat, Alexandre. 2022. Efficient multitool/multiplex gene engineering with TALE-BE. In Frontiers in bioengineering and biotechnology, 10, 1033669. doi:10.3389/fbioe.2022.1033669. https://pubmed.ncbi.nlm.nih.gov/36440442/
6. Andor, Noemi, Simonds, Erin F, Czerwinski, Debra K, Levy, Ronald, Ji, Hanlee P. 2018. Single-cell RNA-Seq of follicular lymphoma reveals malignant B-cell types and coexpression of T-cell immune checkpoints. In Blood, 133, 1119-1129. doi:10.1182/blood-2018-08-862292. https://pubmed.ncbi.nlm.nih.gov/30591526/
7. Jiang, Jiahao, Hiron, Thomas K, Agbaedeng, Thomas A, Davison, Lucy J, O'Callaghan, Chris A. 2024. A Novel Macrophage Subpopulation Conveys Increased Genetic Risk of Coronary Artery Disease. In Circulation research, 135, 6-25. doi:10.1161/CIRCRESAHA.123.324172. https://pubmed.ncbi.nlm.nih.gov/38747151/
8. Wang, Jianxin, Zhang, Guangchen, Sui, Yang, Zhang, Cong, Wu, Changjun. 2020. CD52 Is a Prognostic Biomarker and Associated With Tumor Microenvironment in Breast Cancer. In Frontiers in genetics, 11, 578002. doi:10.3389/fgene.2020.578002. https://pubmed.ncbi.nlm.nih.gov/33240323/
智鼠故事 
